Keros Therapeutics Inc
NASDAQ:KROS
Intrinsic Value
The intrinsic value of one
KROS
stock under the Base Case scenario is
2.7
USD.
Compared to the current market price of 16.15 USD,
Keros Therapeutics Inc
is
Overvalued by 83%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Keros Therapeutics Inc.
The intrinsic value of one
KROS
stock under the Base Case scenario is
2.7
USD.
Compared to the current market price of 16.15 USD,
Keros Therapeutics Inc
is
Overvalued by 83%.